Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Sep;53(3):752-9.

Functional studies of a germ-line polymorphism at codon 47 within the p53 gene

Affiliations

Functional studies of a germ-line polymorphism at codon 47 within the p53 gene

E Felley-Bosco et al. Am J Hum Genet. 1993 Sep.

Abstract

A rare germ-line polymorphism in codon 47 of the p53 gene replaces the wild-type proline (CCG) with a serine (TCG). Restriction analysis of 101 human samples revealed the frequency of the rare allele to be 0% (n = 69) in Caucasians and 4.7% (3/64, n = 32) among African-Americans. To investigate the consequence of this amino acid substitution, a cDNA construct (p53 mut47ser) containing the mutation was introduced into a lung adenocarcinoma cell line (Calu-6) that does not express p53. A growth suppression similar to that obtained after introduction of a wild-type p53 cDNA construct was observed, in contrast to the result obtained by introduction of p53 mut143ala. Furthermore, expression of neither p53 mut47ser nor wild-type p53 was tolerated by growing cells. In transient expression assays, both mut47ser and wild-type p53 activated the expression of a reporter gene linked to a p53 binding sequence (PG13-CAT) and inhibited the expression of the luciferase gene under the control of the Rous sarcoma virus promoter (RSVluc). In the same assay, mut143ala did not activate the expression of PG13-CAT and produced only a slight inhibitory effect on RSVluc. These findings indicate that the p53 variant with a serine at codon 47 should be considered as a rare germ-line polymorphism that does not alter the growth-suppression activity of p53.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6413-7 - PubMed
    1. Cancer Epidemiol Biomarkers Prev. 1992 Sep-Oct;1(6):481-3 - PubMed
    1. Science. 1993 Jan 1;259(5091):84-7 - PubMed
    1. Nature. 1984 Dec 13-19;312(5995):646-9 - PubMed
    1. Nature. 1984 Dec 13-19;312(5995):649-51 - PubMed

Publication types

MeSH terms

LinkOut - more resources